Recombinant Zoster Vaccine (CHO Cell)

BIOLOGICAL4 trials

Sponsors

MAXVAX Biotechnology Limited Liability Company, Ab&B Bio-tech Co., Ltd.JS

Conditions

Herpes ZosterHerpes Zoster Vaccine

Phase 1

Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

Active, not recruitingNCT06851832

Ab&B Bio-tech Co., Ltd.JSHerpes Zoster, Herpes Zoster Vaccine

Start: 2025-02-16End: 2028-09-16Target: 960Updated: 2026-03-31

Phase 3

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Active, not recruitingNCT06447779

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2024-07-13End: 2027-09-30Target: 25000Updated: 2024-10-24

Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).

Not yet recruitingNCT06654700

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2024-12-09End: 2025-05-01Target: 1200Updated: 2024-11-20

A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)

Active, not recruitingNCT07293065

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2025-12-15End: 2028-12-31Target: 12000Updated: 2026-03-10